Man Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-34,463
| Closed | -$8.47M | – | 2297 |
|
|
2022
Q3 | $8.47M | Buy |
+34,463
| New | +$8.47M | 0.04% | 527 |
|
|
2022
Q2 | – | Sell |
-44,499
| Closed | -$14.7M | – | 605 |
|
|
2022
Q1 | $14.7M | Sell |
44,499
-29,740
| -40% | -$9.85M | 0.05% | 441 |
|
|
2021
Q4 | $26.7M | Buy |
74,239
+10,245
| +16% | +$3.68M | 0.09% | 280 |
|
|
2021
Q3 | $20.8M | Buy |
63,994
+41,581
| +186% | +$13.5M | 0.07% | 315 |
|
|
2021
Q2 | $7M | Buy |
22,413
+3,701
| +20% | +$1.16M | 0.02% | 735 |
|
|
2021
Q1 | $5.96M | Sell |
18,712
-1,866
| -9% | -$595K | 0.03% | 610 |
|
|
2020
Q4 | $6.67M | Buy |
20,578
+6,416
| +45% | +$2.08M | 0.03% | 638 |
|
|
2020
Q3 | $3.92M | Sell |
14,162
-4,707
| -25% | -$1.3M | 0.02% | 930 |
|
|
2020
Q2 | $4.56M | Buy |
18,869
+10,330
| +121% | +$2.5M | 0.02% | 717 |
|
|
2020
Q1 | $1.24M | Sell |
8,539
-66,006
| -89% | -$9.58M | 0.01% | 1048 |
|
|
2019
Q4 | $12.7M | Buy |
74,545
+55,859
| +299% | +$9.53M | 0.04% | 562 |
|
|
2019
Q3 | $3.32M | Buy |
18,686
+15,307
| +453% | +$2.72M | 0.01% | 1053 |
|
|
2019
Q2 | $880K | Sell |
3,379
-10,622
| -76% | -$2.77M | ﹤0.01% | 1555 |
|
|
2019
Q1 | $4M | Buy |
14,001
+12,816
| +1,082% | +$3.66M | 0.02% | 1026 |
|
|
2018
Q4 | $385K | Sell |
1,185
-5,102
| -81% | -$1.66M | ﹤0.01% | 1667 |
|
|
2018
Q3 | $2.83M | Sell |
6,287
-2,908
| -32% | -$1.31M | 0.01% | 1258 |
|
|
2018
Q2 | $3.76M | Buy |
9,195
+1,015
| +12% | +$415K | 0.02% | 1071 |
|
|
2018
Q1 | $2.38M | Buy |
+8,180
| New | +$2.38M | 0.01% | 1194 |
|